The requested meta-analysis cannot be performed: none of the supplied records contain fibroblast or keratinocyte conditional IL-17RA KO data. Cell-type-specific IL-17RA evidence here is limited to B cells (8-fold reduction in latently infected GC B cells with B cell-intrinsic deletion) (), with complementary non-skin evidence from global IL-17RA KO emphysema protection (), macrophage IL-17RA-TRAF6-JNK signaling (), and astrocyte IL-17RA/ACT1/NF-kB signaling (). Missing: skin fibroblast/keratinocyte floxed-IL17RA mouse data, psoriasis-relevant conditional KO effect sizes, and cell-type-resolved expression datasets. Confidence: high that the gap is real; low on any skin-cell conclusion.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.